Generic heart medication shown to prolong ovarian cancer patients' survival
In a first-of-its-kind study, researchers demonstrate a benefit in overall survival among epithelial ovarian cancer (EOC) patients receiving generic heart medications known as beta-blockers.
Source: M. D. Anderson Cancer Center - News Releases - Category: Cancer & Oncology Source Type: news
More News: Beta-Blockers | Cancer | Cancer & Oncology | Cardiology | Epithelial Cancer | Heart | Ovarian Cancer | Ovaries | Study